These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 2470772)

  • 1. The significance of antithyroglobulin and antithyroidal microsomal antibodies in patients with hyperthyroidism due to Graves' disease treated with antithyroidal drugs.
    Takaichi Y; Tamai H; Honda K; Nagai K; Kuma K; Nakagawa T
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1097-100. PubMed ID: 2470772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Value of the detection of antithyroid antibodies in thyroid pathology].
    Guillausseau C; Eyquem A; Vincens M; Laurent MF; Leger AF; Savoie JC
    Pathol Biol (Paris); 1985 Jun; 33(6):653-8. PubMed ID: 3900884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects of high and low dosage regimens of antithyroid drugs in the management of Graves' hyperthyroidism.
    Romaldini JH; Bromberg N; Werner RS; Tanaka LM; Rodrigues HF; Werner MC; Farah CS; Reis LC
    J Clin Endocrinol Metab; 1983 Sep; 57(3):563-70. PubMed ID: 6192139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blocking-type anti-TSH receptor antibodies and relation to responsiveness to antithyroid drug therapy and remission in Graves' disease.
    Tada H; Mizuta I; Takano T; Tatsumi KI; Izumi Y; Hidaka Y; Amino N
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):403-8. PubMed ID: 12641621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of thyroid antibodies in hyperthyroid patients treated with antithyroid drugs.
    Khanna CM; Shanker R; Magdum M; Jain SK; Jaggi CB
    J Assoc Physicians India; 1998 Feb; 46(2):176-8. PubMed ID: 11273105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The changes of serum titers of thyroid antibodies in patients of Graves' disease with hyperthyroidism after treatments with antithyroid drugs.
    Huang CS; Tseng FY; Chang TC; Chang CC; Chen FW; Torng JK
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1983 Nov; 16(4):277-82. PubMed ID: 6202467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Graves' disease and Hashimoto's thyroiditis: effects of high doses of antithyroid drugs on thyroid autoantibody levels.
    Romaldini JH; Werner MC; Rodrigues HF; Teixeira VL; Werner RS; Farah CS; Bromberg N
    J Endocrinol Invest; 1986 Jun; 9(3):233-8. PubMed ID: 2428860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of thyroxine in treated Graves' disease. Effects on the level of antibodies to thyroid-stimulating hormone receptors and on the risk of recurrence of hyperthyroidism.
    Hashizume K; Ichikawa K; Sakurai A; Suzuki S; Takeda T; Kobayashi M; Miyamoto T; Arai M; Nagasawa T
    N Engl J Med; 1991 Apr; 324(14):947-53. PubMed ID: 1900575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of circulating thyroid autoantibody levels during and after the therapy with methimazole in patients with Graves' disease.
    Marcocci C; Chiovato L; Mariotti S; Pinchera A
    J Endocrinol Invest; 1982; 5(1):13-9. PubMed ID: 6896520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
    J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
    Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
    J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
    Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of circulating thyroid microsomal antibodies by the tanned red cell haemagglutination technique: its usefulness in the diagnosis of autoimmune thyroid diseases.
    Amino N; Hagen SR; Yamada N; Refetoff S
    Clin Endocrinol (Oxf); 1976 Mar; 5(2):115-25. PubMed ID: 773572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K
    Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in serum thyroglobulin and thyroid autoantibodies in patients with Graves' disease treated with antithyroid drug and their relationship to relapse.
    Gong ST; Chao IM
    J Formos Med Assoc; 1991 Dec; 90(12):1155-62. PubMed ID: 1724781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of serum antithyroid antibodies with lymphocytic infiltration of the thyroid gland: studies of seventy autopsied cases.
    Yoshida H; Amino N; Yagawa K; Uemura K; Satoh M; Miyai K; Kumahara Y
    J Clin Endocrinol Metab; 1978 Jun; 46(6):859-62. PubMed ID: 263468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of spontaneous hypothyroidism in patients with Graves' disease treated with antithyroidal drugs: clinical, immunological, and histological findings in 26 patients.
    Tamai H; Kasagi K; Takaichi Y; Takamatsu J; Komaki G; Matsubayashi S; Konishi J; Kuma K; Kumagai LF; Nagataki S
    J Clin Endocrinol Metab; 1989 Jul; 69(1):49-53. PubMed ID: 2471711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment.
    Tamai H; Hirota Y; Kasagi K; Matsubayashi S; Kuma K; Iida Y; Konishi J; Okimura MC; Walter RM; Kumagai LF
    J Clin Endocrinol Metab; 1987 Apr; 64(4):718-22. PubMed ID: 2434520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in thyroid volume during antithyroid drug therapy for Graves' disease and its relationship to TSH receptor antibodies, TSH and thyroglobulin.
    Yamaguchi Y; Inukai T; Iwashita A; Nishino M; Yamaguchi T; Shohda Y; Shimomura Y; Ohshima K; Kobayashi S; Kobayashi I
    Acta Endocrinol (Copenh); 1990 Oct; 123(4):411-5. PubMed ID: 1978459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.